Contact
searchSearch
HMP Global

Irritable Bowel Syndrome Excellence Forum

Irritable Bowel Syndrome
Excellence Forum
Leaders in the field sharing authoritative insights and institutional best practices.

Gut-Brain Interaction
Referral to the GI Psychologist: IBS-C Roundtable 4
02/05/2026
Megan Riehl, PsyD; Brooks D. Cash, MD; Anthony Lembo, MD
The final expert roundtable session focuses on when patients with IBS-C should be referred to GI psychologists for brain-gut therapy such as gut-directed hypnosis.
The final expert roundtable session focuses on when patients with IBS-C should be referred to GI psychologists for brain-gut therapy such as gut-directed hypnosis.
The final expert roundtable...
02/05/2026
Gastroenterology
Medication
Medical Therapies for IBS-C: Expert Roundtable Part 3
01/29/2026
Anthony Lembo, MD; Megan Riehl, PsyD; Brooks D. Cash, MD
Our expert panel continues as Drs Cash, Lembo, and Riehl delve into the existing medications available to treat IBS-C, from neuromodulators to secretagogues and the sodium/hydrogen exchanger (NHE3) inhibitor tenapanor.
Our expert panel continues as Drs Cash, Lembo, and Riehl delve into the existing medications available to treat IBS-C, from neuromodulators to secretagogues and the sodium/hydrogen exchanger (NHE3) inhibitor tenapanor.
Our expert panel continues as...
01/29/2026
Gastroenterology
Patient Treatment
Treating IBS-C: Expert Roundtable Part 2
01/23/2026
Anthony Lembo, MD; Brooks D. Cash, MD; Megan Riehl, PsyD
In part 2 of this roundtable series, Drs Anthony Lembo, Megan Riehl, and Brooks Cash review the varieties of treatments available for irritable bowel syndrome-constipation, including diet, lifestyle modifications, and medication.
In part 2 of this roundtable series, Drs Anthony Lembo, Megan Riehl, and Brooks Cash review the varieties of treatments available for irritable bowel syndrome-constipation, including diet, lifestyle modifications, and medication.
In part 2 of this roundtable...
01/23/2026
Gastroenterology
Diagnostics
Diagnosing IBS-C: Expert Roundtable Part 1
01/22/2026
Anthony Lembo, MD; Megan Riehl, PsyD; Brooks D. Cash, MD
Diagnosing irritable bowel syndrome with constipation can be challenging. In this video, Drs Anthony Lembo, Brooks Cash, and Megan Riehl discuss the importance and the tests required to make a positive diagnosis rather than a diagnosis of...
Diagnosing irritable bowel syndrome with constipation can be challenging. In this video, Drs Anthony Lembo, Brooks Cash, and Megan Riehl discuss the importance and the tests required to make a positive diagnosis rather than a diagnosis of...
Diagnosing irritable bowel...
01/22/2026
Gastroenterology
Kim Orleck
Clinical Pearls
Kimberly Orleck, PA, on Diagnosing IBS-C
01/13/2026
Kimberly Orleck, ANP-BC
Kimberly Orleck, ANP-BC, reviews the key points to consider when diagnosing a patient with constipation to determine if the condition is irritable bowel syndrome with predominant constipation.
Kimberly Orleck, ANP-BC, reviews the key points to consider when diagnosing a patient with constipation to determine if the condition is irritable bowel syndrome with predominant constipation.
Kimberly Orleck, ANP-BC, reviews...
01/13/2026
Gastroenterology
Lin Chang
Conference Coverage
Lin Chang, MD, on IBS and Pregnancy
10/27/2025
Lin Chang, MD
Dr Chang recaps her presentation at ACG 2025 on how pregnancy can affect irritable bowel syndrome and how to best treat pregnant patients with IBS.
Dr Chang recaps her presentation at ACG 2025 on how pregnancy can affect irritable bowel syndrome and how to best treat pregnant patients with IBS.
Dr Chang recaps her presentation...
10/27/2025
Gastroenterology
Dr Alexander Ford
Podcast
Alexander Ford, MD, Speaks on Amitriptyline as a Potentially Effective Option for IBS
02/09/2024
Alexander Ford, MD
The results of the ATLANTIS trial showed that patients taking amitriptyline were almost twice as likely to report an overall improvement in symptoms of irritable bowel syndrome as those taking a placebo. Co-chief investigator Alexander Ford,...
The results of the ATLANTIS trial showed that patients taking amitriptyline were almost twice as likely to report an overall improvement in symptoms of irritable bowel syndrome as those taking a placebo. Co-chief investigator Alexander Ford,...
The results of the ATLANTIS...
02/09/2024
Gastroenterology
Gut Check logo
Podcast
Gut Check: Brian Lacy, MD, and Megan Riehl, PsyD, on Minding the Gut
01/25/2024
Brian E. Lacy, PhD, MD; Megan Riehl, PsyD
Guest Megan Riehl, PsyD, discusses with Gt Check host Dr Brian Lacy how to diagnose, explain, and treat disorders of gut-brain interaction so patients feel validated and experience relief from symptoms.
Guest Megan Riehl, PsyD, discusses with Gt Check host Dr Brian Lacy how to diagnose, explain, and treat disorders of gut-brain interaction so patients feel validated and experience relief from symptoms.
Guest Megan Riehl, PsyD,...
01/25/2024
Gastroenterology
Conference Coverage
Tal Engel, MD, Reports on Personalized Dietary Therapy for IBS
12/24/2023
Priyam Vora
Dr Engel and colleagues tested an individualized, immune assay-guided diet for irritable bowel syndrome against a sham intervention to see which offered the most relief from symptoms.
Dr Engel and colleagues tested an individualized, immune assay-guided diet for irritable bowel syndrome against a sham intervention to see which offered the most relief from symptoms.
Dr Engel and colleagues tested...
12/24/2023
Gastroenterology
Brian Lacy
Conference Coverage
Brian Lacy, MD, on Tenapanor for IBS-C
10/23/2023
Dr Lacy recaps the key points of his presentation on the use of tenapanor for the treatment of irritable bowel syndrome with constipation, which received the Outstanding Research Award in the Colon Category and was noted as a Newsworthy...
Dr Lacy recaps the key points of his presentation on the use of tenapanor for the treatment of irritable bowel syndrome with constipation, which received the Outstanding Research Award in the Colon Category and was noted as a Newsworthy...
Dr Lacy recaps the key points of...
10/23/2023
Gastroenterology

News

News
Lifetime Alcohol Intake Linked to Colorectal Cancer Risk
02/11/2026
Jessica Garlewicz
For gastroenterologists, the key takeaway is that cumulative alcohol exposure and long-term drinking patterns matter when assessing CRC risk.
For gastroenterologists, the key takeaway is that cumulative alcohol exposure and long-term drinking patterns matter when assessing CRC risk.
For gastroenterologists, the key...
02/11/2026
Gastroenterology
Research Review
New Meta-Analysis Highlights Burden of MASLD Among IBD Patients
02/03/2026
Rebecca Mashaw
The study draws on data from more than 1.5 million individuals, providing the most extensive evidence yet on MASLD’s prevalence and associated factors in patients with Crohn’s disease and ulcerative colitis.
The study draws on data from more than 1.5 million individuals, providing the most extensive evidence yet on MASLD’s prevalence and associated factors in patients with Crohn’s disease and ulcerative colitis.
The study draws on data from...
02/03/2026
Gastroenterology
Emerging Therapies
EC Plus FOLFIRI Improves Response Rates in First-Line BRAF V600E–Mutant Metastatic Colorectal Cancer
01/14/2026
Jessica Garlewicz
For gastroenterologists treating mCRC, EC plus FOLFIRI offers a highly active first-line strategy for patients with BRAF V600E–mutant disease and may represent a new standard of care in this setting.
For gastroenterologists treating mCRC, EC plus FOLFIRI offers a highly active first-line strategy for patients with BRAF V600E–mutant disease and may represent a new standard of care in this setting.
For gastroenterologists treating...
01/14/2026
Gastroenterology
Research Highlights
Short Course Radiation and ctDNA for Rectal Cancer
01/14/2026
Jessica Garlewicz
In an abstract presented at the ASTRO meeting, investigators indicated that circulating tumor DNA may predict recurrence of rectal cancer following short-course radiation therapy.
In an abstract presented at the ASTRO meeting, investigators indicated that circulating tumor DNA may predict recurrence of rectal cancer following short-course radiation therapy.
In an abstract presented at the...
01/14/2026
Gastroenterology
Research Highlights
Persistent MASLD Greatly Increases Diabetes and Cardiovascular Risks, Study Finds
12/15/2025
Rebecca Mashaw
A major cohort study links temporal changes in metabolic-associated steatotic liver disease status to markedly different risks for type 2 diabetes, cardiovascular events, and mortality.
A major cohort study links temporal changes in metabolic-associated steatotic liver disease status to markedly different risks for type 2 diabetes, cardiovascular events, and mortality.
A major cohort study links...
12/15/2025
Gastroenterology
Research Highlights
Sex-Specific Risks Highlight MASLD Burden Across Women’s Lifespan
12/11/2025
Rebecca Mashaw
A new review details how MASLD disproportionately affects women, with key risks linked to PCOS, menopause, and pregnancy.
A new review details how MASLD disproportionately affects women, with key risks linked to PCOS, menopause, and pregnancy.
A new review details how MASLD...
12/11/2025
Gastroenterology
Conference Coverage
Resmetirom Reduces Portal Hypertension Risk and Fibrosis Markers in MASH Cirrhosis at 2 Years
11/04/2025
Jessica Garlewicz
More than one-third of patients with confirmed F4 fibrosis at baseline demonstrated regression to F3 by year 2 of treatment with resmetirom for MASH cirrhosis.
More than one-third of patients with confirmed F4 fibrosis at baseline demonstrated regression to F3 by year 2 of treatment with resmetirom for MASH cirrhosis.
More than one-third of patients...
11/04/2025
Gastroenterology
Conference Coverage
Tirzepatide Bests Semaglutide in Reducing Cardiovascular Events and Mortality in Patients With MASLD/MASH
11/04/2025
Jessica Garlewicz
Tirzepatide treatment was associated with lower risks of cardiovascular-related outcomes, all-cause mortality, and all-cause hospitalizations compared to semaglutide in a large real-world study, according to an abstract presented at the ACG...
Tirzepatide treatment was associated with lower risks of cardiovascular-related outcomes, all-cause mortality, and all-cause hospitalizations compared to semaglutide in a large real-world study, according to an abstract presented at the ACG...
Tirzepatide treatment was...
11/04/2025
Gastroenterology
Conference Coverage
E-Cigarette Use and Risk of Peptic Ulcer Disease: Findings from a National Cohort
10/27/2025
Rebecca Mashaw
In an oral abstract presented at the ACG meeting, investigators concluded that e-cigarette use—both current and former—is independently associated with a risk of peptic ulcer disease.
In an oral abstract presented at the ACG meeting, investigators concluded that e-cigarette use—both current and former—is independently associated with a risk of peptic ulcer disease.
In an oral abstract presented at...
10/27/2025
Gastroenterology
Research Highlights
Liquid Biopsy Shows Potential in Cholangiocarcinoma Care
10/09/2025
Rebecca Mashaw
A recent review highlights liquid biopsy’s emerging role in diagnosis and management of biliary tract cancers.
A recent review highlights liquid biopsy’s emerging role in diagnosis and management of biliary tract cancers.
A recent review highlights...
10/09/2025
Gastroenterology

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use